Cargando…
Edmonton Symptom Assessment Scale may reduce medical visits in patients undergoing chemotherapy for breast cancer
BACKGROUND: Adjuvant chemotherapy is recommended in high-risk breast cancer. However, no universally accepted guidelines exist on pre-chemotherapy assessment. In particular, the number and frequency of medical visits vary according to each institution’s policy. We hypothesised that the Edmonton Symp...
Autores principales: | Sanna, Valeria, Fedele, Palma, Deiana, Giulia, Alicicco, Maria G, Ninniri, Chiara, Santoro, Anna N, Pazzola, Antonio, Fancellu, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346425/ https://www.ncbi.nlm.nih.gov/pubmed/36157162 http://dx.doi.org/10.5306/wjco.v13.i7.577 |
Ejemplares similares
-
Current role of hepatopancreatoduodenectomy for the management of gallbladder cancer and extrahepatic cholangiocarcinoma: A systematic review
por: Fancellu, Alessandro, et al.
Publicado: (2021) -
The Impact on Survival and Morbidity of Portal–Mesenteric Resection During Pancreaticoduodenectomy for Pancreatic Head Adenocarcinoma: A Systematic Review and Meta-Analysis of Comparative Studies
por: Fancellu, Alessandro, et al.
Publicado: (2020) -
De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?
por: Fedele, Palma, et al.
Publicado: (2021) -
How the COVID-19 pandemic has affected the colorectal cancer screening in Italy: A minireview
por: Fancellu, Alessandro, et al.
Publicado: (2022) -
Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series
por: Feo, Claudio F., et al.
Publicado: (2021)